Congress likely to kick the can on covid-era telehealth policies

Intra-Cellular expects Caplyta to rake in about $665-685m in sales this year. Image credit: Lightspring / Shutterstock. Having raised the full-year sales guidance for Caplyta

No­vo Nordisk will broad­en its car­diometa­bol­ic pipeline by pair­ing up with ma­chine learn­ing and drug dis­cov­ery start­up Va­lo Health in a deal that builds on